Close Menu

NEW YORK (GenomeWeb) – Bioinformatics firm Repositive said this week that it plans to launch a so-called Personal Shopper service to help biopharmaceutical companies find cancer models that best meet the criteria for their oncology research projects.

The planned program, which will kick off in October, is part of an ongoing beta test of the company's Cancer Models platform, a new product that has the dual purpose of providing biopharma with a searchable view of existing cancer models and contract research organizations with a platform for showcasing their model inventory.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.

A new analysis finds some cancers receive more nonprofit dollars than others.

An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.

In Science this week: comparative analysis of sex differences in mammal gene expression, and more.